Image pharmaphorum Editor News Hu-manity.co blockchain initiative helps people claim rights... Initiative helps people safeguard personal information News Crescendo hires ex-Roche R&D guru to develop T-cell technolo... Biotech has already raised $70m this year in second funding round News UK gene and cell therapy manufacturing hub clears regulatory... The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built ce News FDA rejects GSK's Nucala in COPD, asking for more clinical d... Blow to GSK's hopes for a new indication Load more results
News Hu-manity.co blockchain initiative helps people claim rights... Initiative helps people safeguard personal information
News Crescendo hires ex-Roche R&D guru to develop T-cell technolo... Biotech has already raised $70m this year in second funding round
News UK gene and cell therapy manufacturing hub clears regulatory... The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built ce
News FDA rejects GSK's Nucala in COPD, asking for more clinical d... Blow to GSK's hopes for a new indication
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.